Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Roots

Showing results (141-150 of 225) with videos related to

Pageof 23
Sort By:
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1979
Demonstration of drug-ethanol interactions by changes in activity of hepatic microsomal oxidase/oxygenase cytochrome P-450 functionG Heinemeyer, A G Hildebrandt, I Roots, et al.
Pharmacopsychiatry|December 17, 2003
Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disordersJ Kirchheiner, L Bertilsson, H Bruus, et al.
American Journal of Human Genetics|September 1, 1995
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activityI Cascorbi, N Drakoulis, J Brockmöller, et al.
Pharmacogenetics|December 1, 1996
Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancerJ Brockmöller, R Kaiser, R Kerb, et al.
Pharmacogenetics|March 27, 2001
Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestryM Dettling, R T Schaub, B Mueller-Oerlinghausen, et al.
Journal of Neuroscience Research|May 15, 1996
Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependentF G Mastronardi, C A Ackerley, B I Roots, et al.
Clinical Pharmacology and Therapeutics|November 5, 1999
Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)A Johne, J Brockmöller, S Bauer, et al.
Atherosclerosis|February 24, 2001
The G protein subunit beta3 and early complications after coronary catheter interventionsC Meisel, M Laule, I Cascorbi, et al.
The Pharmacogenomics Journal|May 17, 2006
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatmentJ Kirchheiner, K Nickchen, J Sasse, et al.
Pharmacopsychiatry|April 13, 2000
Critical evaluation of the effect of valerian extract on sleep structure and sleep qualityF Donath, S Quispe, K Diefenbach, et al.
Pageof 23

Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1979
Demonstration of drug-ethanol interactions by changes in activity of hepatic microsomal oxidase/oxygenase cytochrome P-450 functionG Heinemeyer, A G Hildebrandt, I Roots, et al.
Pharmacopsychiatry|December 17, 2003
Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disordersJ Kirchheiner, L Bertilsson, H Bruus, et al.
American Journal of Human Genetics|September 1, 1995
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activityI Cascorbi, N Drakoulis, J Brockmöller, et al.
Pharmacogenetics|December 1, 1996
Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancerJ Brockmöller, R Kaiser, R Kerb, et al.
Pharmacogenetics|March 27, 2001
Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestryM Dettling, R T Schaub, B Mueller-Oerlinghausen, et al.
Journal of Neuroscience Research|May 15, 1996
Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependentF G Mastronardi, C A Ackerley, B I Roots, et al.
Clinical Pharmacology and Therapeutics|November 5, 1999
Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)A Johne, J Brockmöller, S Bauer, et al.
Atherosclerosis|February 24, 2001
The G protein subunit beta3 and early complications after coronary catheter interventionsC Meisel, M Laule, I Cascorbi, et al.
The Pharmacogenomics Journal|May 17, 2006
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatmentJ Kirchheiner, K Nickchen, J Sasse, et al.
Pharmacopsychiatry|April 13, 2000
Critical evaluation of the effect of valerian extract on sleep structure and sleep qualityF Donath, S Quispe, K Diefenbach, et al.
Pageof 23